Evolution of the implantable cardioverter defibrillator

Lancet

Volumn 359, Issue 9315, 2002, Pages 1362-1363

  Crystal, Eugene ^b   Connolly, Stuart J ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DEVICE; ELECTRODE; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE INJURY; HEART RIGHT VENTRICLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE PACING; HUMAN; NOTE; PATIENT CARE; PRIORITY JOURNAL; SUPERIOR CAVA VEIN; TACHYCARDIA;

EID: 0037140164     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08389-7     Document Type: Note

References (10)

1. Sudden death due to cardiac arrhythmias
2. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies: Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study
3. The implantable cardioverter defibrillator
4. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
5. Retiming the failing heart: Principles and current clinical status of cardiac resynchronization
6. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay
7. Transvenous biventricular defibrillation halves energy requirements in patients
8. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients
9. Energy levels for defibrillation: What is of real clinical importance?
10. Clinical experience with downsized lower energy output implantable cardioverter defibrillators. Ventak Mini II Clinical Investigators